EUDA Health (EUDA) Competitors

$2.33
+0.03 (+1.30%)
(As of 05/17/2024 ET)

EUDA vs. HHGC, NOVV, PPHP, ATPC, UPHL, PIII, LENZ, KZR, TLSA, and AVRO

Should you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include HHG Capital (HHGC), Nova Vision Acquisition (NOVV), PHP Ventures Acquisition (PPHP), Agape ATP (ATPC), UpHealth (UPHL), P3 Health Partners (PIII), LENZ Therapeutics (LENZ), Kezar Life Sciences (KZR), Tiziana Life Sciences (TLSA), and AVROBIO (AVRO).

EUDA Health vs.

HHG Capital (NASDAQ:HHGC) and EUDA Health (NASDAQ:EUDA) are both small-cap unclassified companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership.

HHG Capital has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.27, suggesting that its stock price is 127% less volatile than the S&P 500.

HHG Capital's return on equity of 0.00% beat EUDA Health's return on equity.

Company Net Margins Return on Equity Return on Assets
HHG CapitalN/A -77.53% 3.88%
EUDA Health N/A N/A N/A

HHG Capital has higher earnings, but lower revenue than EUDA Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HHG CapitalN/AN/A$1.37M$0.07162.86
EUDA Health$3.71M15.47-$24.88MN/AN/A

In the previous week, EUDA Health had 1 more articles in the media than HHG Capital. MarketBeat recorded 1 mentions for EUDA Health and 0 mentions for HHG Capital. EUDA Health's average media sentiment score of 0.00 beat HHG Capital's score of -0.45 indicating that HHG Capital is being referred to more favorably in the media.

Company Overall Sentiment
HHG Capital Neutral
EUDA Health Neutral

HHG Capital and EUDA Health both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
HHG CapitalN/AN/A
EUDA HealthN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HHG Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

4.0% of HHG Capital shares are held by institutional investors. Comparatively, 4.4% of EUDA Health shares are held by institutional investors. 5.0% of HHG Capital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

HHG Capital beats EUDA Health on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$57.38M$859.16M$5.24B$7.99B
Dividend YieldN/A1.66%44.24%3.91%
P/E RatioN/A18.76100.5014.80
Price / Sales15.473.012,370.7280.86
Price / CashN/A19.1836.7931.98
Price / Book-13.712.365.494.64
Net Income-$24.88M-$15.00M$105.95M$217.28M
7 Day Performance4.95%-0.16%1.42%2.90%
1 Month Performance33.14%10.98%4.96%6.66%
1 Year Performance51.30%17.08%7.84%9.89%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HHGC
HHG Capital
0 of 5 stars
$11.32
+0.7%
N/A+8.6%$57.17MN/A161.722,021Upcoming Earnings
NOVV
Nova Vision Acquisition
0 of 5 stars
$11.92
flat
N/AN/A$39.57MN/A596.302,021Positive News
PPHP
PHP Ventures Acquisition
0 of 5 stars
$11.07
flat
N/AN/A$28.75MN/A-27.672,021
ATPC
Agape ATP
0 of 5 stars
$0.24
flat
N/AN/A$18.59M$1.43M-12.0821Earnings Report
Negative News
Gap Up
UPHL
UpHealth
0 of 5 stars
$0.83
-1.2%
N/AN/A$15.65M$130M-0.26374Gap Down
PIII
P3 Health Partners
1.3967 of 5 stars
$0.67
+6.4%
$4.75
+609.3%
-81.1%$211.56M$1.27B-1.14400
LENZ
LENZ Therapeutics
4.2061 of 5 stars
$15.72
-1.2%
$31.33
+99.3%
N/A$57.38MN/A0.00N/AInsider Buying
KZR
Kezar Life Sciences
3.5463 of 5 stars
$0.79
+5.3%
$11.00
+1,293.3%
-71.0%$57.48M$7M-0.5658Short Interest ↑
News Coverage
TLSA
Tiziana Life Sciences
0.2774 of 5 stars
$0.56
-8.2%
N/A-10.7%$57.55MN/A0.009Gap Up
AVRO
AVROBIO
3.027 of 5 stars
$1.29
-4.4%
$2.00
+55.0%
+65.5%$57.91MN/A0.0013Insider Buying
Short Interest ↑
News Coverage
High Trading Volume

Related Companies and Tools

This page (NASDAQ:EUDA) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners